Dr. Holtz earned both his J.D. and Ph.D. from Washington University in St. Louis. As a doctoral candidate, he studied molecular mechanisms of cell death in a model of Parkinson’s disease. Additionally, Dr. Holtz has research experience working for a major biotechnology company. Dr. Holtz has published in peer reviewed scientific journals such as Journal of Biological Chemistry, Journal of Neurochemistry, Neurobiology of Disease, and Antioxidants & Redox Signaling. He uses his extensive experience in molecular cloning, DNA and RNA purification, cell culture, immunohistochemistry, protein expression, protein purification, quantitative PCR, gene array analysis, and microscopy in the preparation and prosecution of biotechnology and pharmaceutical patent applications.